Skip to main content
F

Formosa Laboratories, Inc. — Investor Relations & Filings

Ticker · 4746 TW Manufacturing
Filings indexed 1,860 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About Formosa Laboratories, Inc.

https://www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
112年第3季財務報告書 — 202301_4746_AIA.pdf
Regulatory Filings
2023-12-29 Chinese
112年第3季財務報告書 — 202301_4746_AI1.pdf
Regulatory Filings
2023-12-29 Chinese
111年企業社會責任報告書
Regulatory Filings
2023-12-27 Chinese
112年12月8日內部人設質解質
Regulatory Filings
2023-12-11 Chinese
112年11月內部人持股異動(事後)
Regulatory Filings
2023-12-06 Chinese
112年11月董事會成員及持股
Regulatory Filings
2023-12-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.